ENDRA Life Sciences (NDRA) Other Operating Expenses (2016 - 2026)

ENDRA Life Sciences (NDRA) has 11 years of Other Operating Expenses data on file, last reported at $4278.0 in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $4278.0, down 93.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $124757.0 (down 68.92% YoY), and the FY2025 annual result was $189470.0, down 66.82% from the prior year.
• Other Operating Expenses declined to $4278.0 in Q1 2026 per NDRA's latest filing, from $6360.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $420439.0 in Q3 2022 and troughed at $4278.0 in Q1 2026.
• A 5-year average of $177323.1 and a median of $162952.0 in 2024 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2026: Other Operating Expenses jumped 111.21% in 2022, then tumbled 93.8% in 2026.
• A 5-year view of Other Operating Expenses shows it stood at $326769.0 in 2022, then plunged by 54.76% to $147833.0 in 2023, then tumbled by 41.64% to $86271.0 in 2024, then slumped by 92.63% to $6360.0 in 2025, then slumped by 32.74% to $4278.0 in 2026.
• Business Quant data shows NDRA's Other Operating Expenses at $4278.0 in Q1 2026, $6360.0 in Q4 2025, and $45285.0 in Q3 2025.